Kung-Pern Wang

Title: Innovations of Kung-Pern Wang

Introduction

Kung-Pern Wang is a notable inventor based in Bothell, WA (US). He has made significant contributions to the field of biochemistry, particularly in the development of compounds that target specific diseases. His work focuses on innovative solutions that can potentially improve treatment outcomes for patients suffering from various conditions.

Latest Patents

Kung-Pern Wang holds a patent for "Quaternized nicotinamide adenine dinucleotide salvage pathway inhibitor conjugates." This patent describes compounds and compositions where a NAMPT Drug Unit is conjugated to a targeting Ligand Unit through quaternization by a Linker Unit. The design allows for the release of a NAMPT inhibitor compound or derivative at the targeted site of action. The methods outlined in the patent aim to treat diseases characterized by targeted abnormal cells, such as cancer or autoimmune diseases.

Career Highlights

Wang is currently associated with Seagen Inc., a company known for its focus on innovative cancer therapies. His work at Seagen has allowed him to contribute to groundbreaking research and development in the pharmaceutical industry. With a patent portfolio that includes 1 patent, Wang continues to push the boundaries of medical science.

Collaborations

Throughout his career, Kung-Pern Wang has collaborated with esteemed colleagues, including Robert Lyon and Christopher Scott Neumann. These collaborations have fostered an environment of innovation and have led to advancements in their respective fields.

Conclusion

Kung-Pern Wang's contributions to the field of biochemistry and his innovative patent work exemplify the impact of dedicated inventors in advancing medical science. His ongoing efforts at Seagen Inc. highlight the importance of collaboration and innovation in developing effective treatments for challenging diseases.